Search Details

Word: generics (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...Oracle tends to be a generic system and Harvard has some uniqueness," Segall says. "They assumed it would work in some key areas, but you never know where it won't work until...

Author: By James Y. Stern, CRIMSON STAFF WRITERS | Title: University Accounting Overhaul Year Behind, Over Budget | 3/9/1999 | See Source »

Indeed, the price of drugs has been both rising and falling. Spending on all prescriptions amounted to $100 billion last year and is growing 11% to 14% annually. Competition among generic drugmakers has depressed prices nearly 40% since 1995, saving consumers between $8 billion and $10 billion annually. As generics have got cheaper, their share of all drugs prescribed has risen to nearly 45%, almost tripling since 1984. On the other hand, since 1995 consumers have paid nearly 20% more for brand-name medications...

Author: /time Magazine | Title: Who's Really Raising Drug Prices? | 3/8/1999 | See Source »

...drugs. Last year the company helped found a lobbying group called the Campaign for Fair Pharmaceutical Competition. The group is currently pushing to eliminate sections of the Waxman-Hatch Act, a landmark 1984 law designed to promote drug competition. One target: a provision that prevents the FDA from reviewing generic-drug applications for 30 months if the patent holder sues...

Author: /time Magazine | Title: Who's Really Raising Drug Prices? | 3/8/1999 | See Source »

...opposing lobbyists have a slightly different spin. Proprietary medications can work better and sometimes protect consumers from potentially unsafe or ineffective generic compounds, according to Alan Holmer, president of PhRMA, a lobby for the brand holders. He derides Mylan's lobbying as "nothing more than a brazen attempt to deflect attention from the generic industry's embarrassment at its recent dramatic price increase and calls for antitrust investigations of their practices...

Author: /time Magazine | Title: Who's Really Raising Drug Prices? | 3/8/1999 | See Source »

Whatever happens to Mylan, America's generic-drug industry is likely to emerge much stronger from the current turmoil. Even with delays, brand-name drugs that now account for sales of more than $40 billion a year could become available in generic form by 2008. Based on current pricing, consumers might save an additional $16 billion. And that's not too hard to swallow...

Author: /time Magazine | Title: Who's Really Raising Drug Prices? | 3/8/1999 | See Source »

Previous | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | Next